Supplementary Table 3 from Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates
Published in 2024 by
Candace L. Haddox,
Michael J. Nathenson,
Emanuele Mazzola,
Jia-Ren Lin,
Joanna Baginska,
Allison Nau,
Jason L. Weirather,
Edwin Choy,
Adrian Marino-Enriquez 
,
Jeffrey A. Morgan,
Gregory M. Cote,
Priscilla Merriam,
Andrew J. Wagner,
Peter K. Sorger,
Sandro Santagata
and other authors.
,
Jeffrey A. Morgan,
Gregory M. Cote,
Priscilla Merriam,
Andrew J. Wagner,
Peter K. Sorger,
Sandro Santagata
and other authors.
